Noriaki Koshikawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Noriaki Koshikawa has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Kazunori Adachi
Department of Pharmacology, Nihon University School of Dentistry
4 shared publicationsMichiko Sato
Department of Pharmacology, Nihon University School of Dentistry, 1-8-13 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-8310, Japan
4 shared publicationsShin Nakamura
Department of Oral and Maxillofacial Surgery, Nihon University School of Dentistry
4 shared publicationsAlexander R. Cools
Radboud University of Nijmegen
3 shared publicationsHiroko Ikeda
Department of Pharmacology, Nihon University School of Dentistry, 1-8-13 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-8310, Japan; Division of Oral and Craniomaxillofacial Research, Dental Research Centre, Nihon University School of Dentistry, Chiyoda-ku, Tokyo 101-8310, Japan
3 shared publicationsMegumi Hasegawa
Department of Pharmacology, Nihon University School of Dentistry, 1-8-13 Kanda-Surugadai, Chiyoda, Tokyo 101-8310, Japan
3 shared publications
Latest Publications
- Open Access
- 1 January 2010
- Published by SAGE Publications in Molecular Pain
- Vol. 6 (1) , 59
Purinergic Receptors are Involved in Tooth-Pulp Evoked Nocifensive Behavior and Brainstem Neuronal Activity
Background: To evaluate whether P2X receptors are involved in responses to noxious pulp stimulation, the P2X3and P2X2/3receptor agonist α,β-methyleneATP (α,β-meATP) was applied to the molar tooth pulp and nocifensive behavior and extracellular-signal regulated kinase (ERK) phosphorylation in trigeminal spinal subnucleus caudalis (Vc), trigeminal spinal subnucleus interpolaris (Vi), upper cervical spinal cord (C1/C2) and paratrigeminal nucleus (Pa5) neurons were analyzed in rats.Results: Genioglossus (GG) muscle activity was evoked by pulpal application of 100 mM α,β-meATP and was significantly larger than GG activity following vehicle (phosphate-buffered saline PBS) application (p < 0.01). The enhanced GG muscle activity following 100 mM α,β-meATP was significantly reduced (p < 0.05) by co-application of 1 mM TNP-ATP (P2X1, P2X3and, P2X2/3antagonist). A large number of pERK-LI cells were expressed in the Vc, Vi/Vc, C1/C2 and Pa5 at 5 min following pulpal application of 100 mM α,β-meATP compared to PBS application to the pulp (p < 0.05). The pERK-LI cell expression and GG muscle activity induced by 100 mM α,β-meATP pulpal application were significantly reduced after intrathecal injection of the MAPK/ERK kinase (MEK) inhibitor PD 98059 and by pulpal co-application of 1 mM TNP-ATP (p < 0.05).Conclusions: The present findings suggest that activation of P2X3and P2X2/3receptors in the tooth pulp is sufficient to elicit nociceptive behavioral responses and trigeminal brainstem neuronal activity.
- 1 January 2010
- Published by SAGE Publications in Molecular Pain
- Vol. 6 (1) , 59
Open AccessPurinergic Receptors are Involved in Tooth-Pulp Evoked Nocifensive Behavior and Brainstem Neuronal Activity
Background: To evaluate whether P2X receptors are involved in responses to noxious pulp stimulation, the P2X3and P2X2/3receptor agonist α,β-methyleneATP (α,β-meATP) was applied to the molar tooth pulp and nocifensive behavior and extracellular-signal regulated kinase (ERK) phosphorylation in trigeminal spinal subnucleus caudalis (Vc), trigeminal spinal subnucleus interpolaris (Vi), upper cervical spinal cord (C1/C2) and paratrigeminal nucleus (Pa5) neurons were analyzed in rats.Results: Genioglossus (GG) muscle activity was evoked by pulpal application of 100 mM α,β-meATP and was significantly larger than GG activity following vehicle (phosphate-buffered saline PBS) application (p < 0.01). The enhanced GG muscle activity following 100 mM α,β-meATP was significantly reduced (p < 0.05) by co-application of 1 mM TNP-ATP (P2X1, P2X3and, P2X2/3antagonist). A large number of pERK-LI cells were expressed in the Vc, Vi/Vc, C1/C2 and Pa5 at 5 min following pulpal application of 100 mM α,β-meATP compared to PBS application to the pulp (p < 0.05). The pERK-LI cell expression and GG muscle activity induced by 100 mM α,β-meATP pulpal application were significantly reduced after intrathecal injection of the MAPK/ERK kinase (MEK) inhibitor PD 98059 and by pulpal co-application of 1 mM TNP-ATP (p < 0.05).Conclusions: The present findings suggest that activation of P2X3and P2X2/3receptors in the tooth pulp is sufficient to elicit nociceptive behavioral responses and trigeminal brainstem neuronal activity.
- 1 January 2010
- Published by Japanese Association for Oral Biology in Journal of Oral Biosciences
- Vol. 52 (4) , 336-343
Dopamine Receptor Subtypes and Orofacial Movement Topographies: Studies with Mutant Models
- 1 January 2010
- Published by Japanese Association for Oral Biology in Journal of Oral Biosciences
- Vol. 52 (4) , 336-343
Dopamine Receptor Subtypes and Orofacial Movement Topographies: Studies with Mutant Models
- 27 March 2008
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 115 (7) , 1079-1085
Behavioural characterisation of rats exposed neonatally to bisphenol-A: responses to a novel environment and to methylphenidate challenge in a putative model of attention-deficit hyperactivity disorder
Neonatal exposure of rats to bisphenol-A, an endocrine disruptor, has recently been proposed as a possible animal model of attention-deficit hyperactivity disorder (ADHD), because such rats exhibit motor hyperactivity. To strengthen the face validity of this animal model, the present study replicated the original experiments and additionally analysed both changes in habituation to a novel environment and behavioural responses to methylphenidate, the two phenomena known to be altered in ADHD. Single intracisternal administration of bisphenol-A (20 and 40 μg) into 5-day-old male Wistar rats impaired habituation to a novel environment in the light, but not the dark, phase at 4 weeks of age. Thus, habituation as assessed by time-dependent decrease of locomotor activity, rearing, sniffing and grooming was significantly reduced in bisphenol-A-pretreated rats. Methylphenidate (1 and 3 mg/kg, i.p.) dose-dependently enhanced locomotor activity in both vehicle-pretreated and bisphenol-A-pretreated rats during both the dark and the light phases. Thus, the effects of methylphenidate did not differ between bisphenol-A-pretreated and vehicle-pretreated rats. Apart from a slight methylphenidate-induced increase in rearing and sniffing in bisphenol-A (20 μg)-pretreated rats, the overall effects of methylphenidate on rearing, sniffing and grooming were similar in both vehicle- and bisphenol-A-pretreated rats. It is concluded that neonatal exposure of rats to bisphenol-A is an animal model with limited face validity for ADHD, because the motor hyperactivity and reduced habituation to a novel environment are not accompanied by altered responses to methylphenidate.
- 27 March 2008
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 115 (7) , 1079-1085
Behavioural characterisation of rats exposed neonatally to bisphenol-A: responses to a novel environment and to methylphenidate challenge in a putative model of attention-deficit hyperactivity disorder
Neonatal exposure of rats to bisphenol-A, an endocrine disruptor, has recently been proposed as a possible animal model of attention-deficit hyperactivity disorder (ADHD), because such rats exhibit motor hyperactivity. To strengthen the face validity of this animal model, the present study replicated the original experiments and additionally analysed both changes in habituation to a novel environment and behavioural responses to methylphenidate, the two phenomena known to be altered in ADHD. Single intracisternal administration of bisphenol-A (20 and 40 μg) into 5-day-old male Wistar rats impaired habituation to a novel environment in the light, but not the dark, phase at 4 weeks of age. Thus, habituation as assessed by time-dependent decrease of locomotor activity, rearing, sniffing and grooming was significantly reduced in bisphenol-A-pretreated rats. Methylphenidate (1 and 3 mg/kg, i.p.) dose-dependently enhanced locomotor activity in both vehicle-pretreated and bisphenol-A-pretreated rats during both the dark and the light phases. Thus, the effects of methylphenidate did not differ between bisphenol-A-pretreated and vehicle-pretreated rats. Apart from a slight methylphenidate-induced increase in rearing and sniffing in bisphenol-A (20 μg)-pretreated rats, the overall effects of methylphenidate on rearing, sniffing and grooming were similar in both vehicle- and bisphenol-A-pretreated rats. It is concluded that neonatal exposure of rats to bisphenol-A is an animal model with limited face validity for ADHD, because the motor hyperactivity and reduced habituation to a novel environment are not accompanied by altered responses to methylphenidate.
- 1 October 2006
- Published by IOS Press in Folia Pharmacologica Japonica
- Vol. 128 (4) , 244-9, 243
[Observation and recording of mouse jaw movements with a novel restrictor system and a behavioral check list].
- 1 October 2006
- Published by IOS Press in Folia Pharmacologica Japonica
- Vol. 128 (4) , 244-9, 243
[Observation and recording of mouse jaw movements with a novel restrictor system and a behavioral check list].
- 30 June 2004
- Published by Elsevier in Neuropharmacology
- Vol. 46 (8) , 1089-1096
Role of μ- and δ-opioid receptors in the nucleus accumbens in turning behaviour of rats
- 30 June 2004
- Published by Elsevier in Neuropharmacology
- Vol. 46 (8) , 1089-1096
Role of μ- and δ-opioid receptors in the nucleus accumbens in turning behaviour of rats
- 1 June 2004
- Published by Elsevier in Neuropharmacology
- Vol. 46 (8) , 1082-1088
GABAA and GABAB receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour
- 1 June 2004
- Published by Elsevier in Neuropharmacology
- Vol. 46 (8) , 1082-1088
GABAA and GABAB receptors in the nucleus accumbens shell differentially modulate dopamine and acetylcholine receptor-mediated turning behaviour
- Open Access
- 1 January 2003
- Published by Nihon University School of Dentistry in Journal of Oral Science
- Vol. 45 (2) , 75-83
Altered pre- and postsynaptic dopamine receptor functions in spontaneously hypertensive rat: an animal model of attention-deficit hyperactivity disorder
Dopamine receptor function in spontaneously hypertensive rats (SHR) and in control progenitor Wistar-Kyoto (WKY) rats was assessed from their dopamine D1-like/D2-like receptor-mediated jaw movements and dopamine release from the nucleus accumbens and from the ventrolateral striatum measured by an in vivo microdialysis technique. Spontaneous locomotor activity and rearing were significantly higher in SHR than in WKY rats. Coadministration of SKF 38393 (1.0, 2.0 and 3.0 mg/kg), a dopamine D1-like receptor agonist, and quinpirole (1.0 mg/kg), a dopamine D2-like receptor agonist, produced repetitive jaw movements in WKY rats in a dosedependent manner. However, this synergism was not evident in SHR. Basal dopamine levels in both the nucleus accumbens and the ventrolateral striatum were lower in SHR than WKY rats, though the levels of dopamine were lower in the nucleus accumbens than the ventrolateral striatum in both strains. After infusion of quinpirole (100 μM for 180 min) the dopamine levels in both regions were reduced. In the nucleus accumbens, the quinpirole-mediated reduction of dopamine release at 40 min and 60 min after infusion was larger in SHR than WKY rats, whereas this difference between the SHR and WKY rats was small in the ventrolateral striatum. The present study therefore suggests that, when compared to WKY rats, postsynaptic dopamine D1-like/D2-like receptors in the SHR are hyposensitive, while presynaptic dopamine D2-like receptors located particularly in the nucleus accumbens are hypersensitive. (J. Oral Sci. 45, 75-83, 2003)
- 1 January 2003
- Published by Nihon University School of Dentistry in Journal of Oral Science
- Vol. 45 (2) , 75-83
Open AccessAltered pre- and postsynaptic dopamine receptor functions in spontaneously hypertensive rat: an animal model of attention-deficit hyperactivity disorder
Dopamine receptor function in spontaneously hypertensive rats (SHR) and in control progenitor Wistar-Kyoto (WKY) rats was assessed from their dopamine D1-like/D2-like receptor-mediated jaw movements and dopamine release from the nucleus accumbens and from the ventrolateral striatum measured by an in vivo microdialysis technique. Spontaneous locomotor activity and rearing were significantly higher in SHR than in WKY rats. Coadministration of SKF 38393 (1.0, 2.0 and 3.0 mg/kg), a dopamine D1-like receptor agonist, and quinpirole (1.0 mg/kg), a dopamine D2-like receptor agonist, produced repetitive jaw movements in WKY rats in a dosedependent manner. However, this synergism was not evident in SHR. Basal dopamine levels in both the nucleus accumbens and the ventrolateral striatum were lower in SHR than WKY rats, though the levels of dopamine were lower in the nucleus accumbens than the ventrolateral striatum in both strains. After infusion of quinpirole (100 μM for 180 min) the dopamine levels in both regions were reduced. In the nucleus accumbens, the quinpirole-mediated reduction of dopamine release at 40 min and 60 min after infusion was larger in SHR than WKY rats, whereas this difference between the SHR and WKY rats was small in the ventrolateral striatum. The present study therefore suggests that, when compared to WKY rats, postsynaptic dopamine D1-like/D2-like receptors in the SHR are hyposensitive, while presynaptic dopamine D2-like receptors located particularly in the nucleus accumbens are hypersensitive. (J. Oral Sci. 45, 75-83, 2003)
- 26 April 2002
- Published by Elsevier in European Journal of Pharmacology
- Vol. 441 (3) , 217-219
Erratum to “Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dompamine D1-like receptors in jaw movements” [Eur. J. Pharmacol. 423 (2001) 171–178]
- 26 April 2002
- Published by Elsevier in European Journal of Pharmacology
- Vol. 441 (3) , 217-219
Erratum to “Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dompamine D1-like receptors in jaw movements” [Eur. J. Pharmacol. 423 (2001) 171–178]
- 5 July 2001
- Published by Elsevier in European Journal of Pharmacology
- Vol. 423 (2-3) , 171-178
Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D1-like receptors in jaw movements
- 5 July 2001
- Published by Elsevier in European Journal of Pharmacology
- Vol. 423 (2-3) , 171-178
Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D1-like receptors in jaw movements
- 1 February 1999
- Published by Elsevier in European Journal of Pharmacology
- Vol. 367 (2-3) , 143-149
SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism
- 1 February 1999
- Published by Elsevier in European Journal of Pharmacology
- Vol. 367 (2-3) , 143-149
SK&F 83959 and non-cyclase-coupled dopamine D1-like receptors in jaw movements via dopamine D1-like/D2-like receptor synergism